Notice of Intent for Sole Source Award
Veterans Affairs · VETERANS AFFAIRS, DEPARTMENT OF
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C770AP270038 in this department, oldest first.
- Aug 4, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
SPECIAL NOTICE OF INTENT TO AWARD A SOLE SOURCE PROCUREMENT. THIS IS NOT A REQUEST FOR QUOTE. THIS IS A NOTICE OF THE GOVERNMENT'S INTENT TO ISSUE A SOLE SOURCE AWARD. This Notice is to announce that the Department of Veteran Affairs, Network Contracting Office (NCO) 15, hereby announces its notice of intent to negotiate with Medline Industries LLC, a Large Business on a sole source basis to provide medical and surgical item consistent with their current contract 36C77021D0010 in accordance with Revolutionary FAR Overhaul (RFO) 6.103-1 for a Period of Performance of 10/01/2026 with a possible … (show all)
6 month extension under FAR 52.217-9 while the follow on RFP for these services are recompeted. This procurement will be a new requirement utilizing a Firm Fixed-Price (FFP) contract for one (1) year plus one (1) six-month option. The contract requires the use of the VA Health Level 7 system that has been approved by the Veterans Affairs Office of Information Technology Office. The requirement also has the need for the vendor to receive and process approximately 44,000 prescriptions of medical and surgical supplies per business day and the stock on hand for the prescription�s shipment average within 48 hours. Contractor will adhere to federal, state and local regulations for all actions under the awarded contract, to include: Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Federal, State and Local codes and laws or regulations, including renewal of required (Federal or State) certifications, as applicable, as well as postal and shipping regulations There are no other contractors that have the ability to supplement the VA this way without significant time to implement vendor processing capabilities in accordance with program requirements. Not using the current contractor to maintain the current prescription fulfillment would jeopardize timely prescription fulfillment for Veterans. To ensure safe, reliable, and continuous service to Veterans the interim contact will be put into place while the follow-on Request For Proposal (RFP) is being finalized for release in Quarter 1 of United States Government Fiscal Year 2027. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. However, all responsible sources may submit a capability statement to the network contracting office (NCO) 15, via email to phillip.reuwer@va.gov to express their ability to provide these products for future needs. The capabilities statement should include the capability to fulfill the product stock and fulfillment timelines as required by the current contract and the ability or present capacity to receive information via the Health Level 7 system which would include current certification as approved by the VA Office of Technology within 5 days of these notices posting.
Who won similar work
470 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Veterans Affairs), same product/service code (PSC) 6505.
Single-winner award sizes (468): middle half $108K to $5.1M, median $724K; range $6K to $8.0B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| EXELAN PHARMACEUTICALS INC | 38 | $293.6M | Mar 5, 2026 |
| Pharmacy Buying Association, Inc. | 32 | $6.6M | Jul 28, 2026 |
| GOLDEN STATE MEDICAL SUPPLY, INC. | 29 | $317.4M | Sep 15, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH · $254.2B | 20 | $28.2M | Oct 2, 2026 |
| PROGENICS PHARMACEUTICALS INC | 17 | $320.1M | Aug 5, 2026 |
| MELLING LLC | 15 | $3.5M | Sep 10, 2026 |
| DERRAH MORRISON ENTERPRISES LLC | 15 | $904K | Aug 27, 2026 |
| HYGEN PHARMACEUTICALS INC | 14 | $582K | Jul 30, 2026 |
| DISABLED VETERANS HAWAII LLC | 10 | $1.4M | Mar 10, 2026 |
| RLS (USA) INC. | 8 | $25.0M | Oct 2, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $CAH reported $254.2B revenue (fiscal year ending Jun 30, 2026). The median single-winner award in these 468 past awards, $724K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 2, 2026RLS (USA) INC.$6.8M6505--RadiopharmaceuticalsNo listed company matched (Materiality N/A)
- Oct 2, 2026CARDINAL HEALTH 414, LLC$4.6M6505--Lab Supplies | Radiopharm | New 5 year consolidation Lebanon & Pittsburgh - Illuccix | 595 and 646 | EDA: 10/01/2026 VLD | Status: moved to collaboration, once actionable will be assigned to ChrMateriality: <0.01% of $CAH revenue (Low) SEC
- Oct 1, 2026RLS (USA) INC.$5.2M6505--Supplies - Radioactive Isotopes - Ann ArborNo listed company matched (Materiality N/A)
- Oct 1, 2026Novartis Pharmaceuticals Corporation$3.1MPLUVICTO - Northern California VANo listed company matched (Materiality N/A)
- Oct 1, 2026SOFIE Co. DULLES 20166$558K6505--PET MRI Radiopharmaceuticals, DetroitNo listed company matched (Materiality N/A)
- Oct 1, 2026OPTUM INFUSION SERVICES 308, LLC$1.9M6505--Chemo Compounding - East OrangeNo listed company matched (Materiality N/A)
- Oct 1, 2026CARDINAL HEALTH 414, LLC$638K6505--Fluorodeoxyglucose (FDG) RadiopharmaceuticalMateriality: <0.01% of $CAH revenue (Low) SEC
- Oct 1, 2026VALNEVA USA, INC.$787K6505--JAPANESE ENCEPHALITIS VIRUS VACCINE IXIARONo listed company matched (Materiality N/A)
- Oct 1, 2026Novartis Pharmaceuticals Corporation$4.1MPLUVICTO Palo Alto VANo listed company matched (Materiality N/A)
- Oct 1, 2026CARDINAL HEALTH 414, LLC$53K6505--VALL Iodine Isotope IDIQMateriality: <0.01% of $CAH revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.